Repeatability and Stability of Healthy Skin Features on OCT
Assessing the Stability and Repeatability of OCT Features in Healthy Skin: a Test-retest Study
1 other identifier
observational
20
1 country
1
Brief Summary
A test-retest study on the stability and repeatability of healthy skin features on OCT
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2022
CompletedFirst Posted
Study publicly available on registry
August 26, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFebruary 16, 2024
February 1, 2024
1.3 years
August 24, 2022
February 15, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Repeatable hand-crafted radiomics-features
The number of HRFs that are repeatable in a test-retest setting
Interval of 10 minutes
Interclass Correlation Coefficient (ICC)
Intraclass Correlation Coefficient (ICC) will be used to assess the correlation and repeatability of the HRFs resulting from OCT scans. ICC will be calculated after all scans have been obtained. ICC will be used to rank the HRFs. This statistical test is commonly used reliability index in test re-test studies.
1 month
Interventions
Optical coherence tomography is a non-invasive scanner which generates real-time in-vivo images of the skin and its adnexal structures. Images are generated by light-interferometry.
Eligibility Criteria
A total of 30 healthy volunteers (colleages from the department of dermatology (MUMC+) and precision medicine (UM) will be asked to participate in this study. They must have at least three naevi.
You may qualify if:
- At least18 years of age
You may not qualify if:
- Unable to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht UMC+
Maastricht, Limburg, 6229HX, Netherlands
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2022
First Posted
August 26, 2022
Study Start
September 1, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
February 16, 2024
Record last verified: 2024-02